Presentation Information
[1S14a-1]Multi-Modality Strategy for Creating Innovative Drugs
○Narihiro Toda (Modality Research Laboratories I, Research Function, R&D Division, Daiichi Sankyo Co., Ltd.)
Comment
To browse or post comments, you must log in.Log in